Comprehensive molecular characterization of gastric cancer patients from phase II second-line ramucirumab plus paclitaxel therapy trial
Abstract Background Gastric cancer (GC) is a heterogenous disease consisted of several subtypes with distinct molecular traits. The clinical implication of molecular classification has been limited especially in association with treatment efficacy of ramucirumab or various targeted agents. Methods W...
Spremljeno u:
| Glavni autori: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMC
2021-01-01
|
| Serija: | Genome Medicine |
| Teme: | |
| Online pristup: | https://doi.org/10.1186/s13073-021-00826-w |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|